Signatur Biosciences

📍 London, United Kingdom🗓 Founded 2022👥 11 employees💰 Last funded Apr 2025
Biotechnology Research🌐 signatur.bio
Website LinkedIn
Signatur Biosciences makes precision diagnostics more accessible, starting by bringing breast cancer testing within reach for women around the world. Traditional tests used to guide therapy are slow and expensive due to their reliance on complex, centralized facilities. Our tests are designed to seamlessly integrate with standard instruments and workflows already in place in every clinical lab. Our assays empower local labs to deliver results in hours instead of weeks and at a fraction of the cost, significantly increasing accessibility, including for underserved patient populations. Signatur Biosciences is a spinout backed by YCombinator, founded by bioengineers from Imperial College and Oxford University.
5
Total investors
4
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography5 countries
Canada
1
Switzerland
1
Germany
1
United States
1
Belgium
1
Investor activity2022–2025 · investors recorded per year
202212023320251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Signatur Biosciences?
Signatur Biosciences has 5 investors on record on gritt.io, including 4 early-stage backers, 1 mid-stage.
When did Signatur Biosciences last raise funding?
The most recent investment in Signatur Biosciences recorded on gritt.io was in April 2025.
When was Signatur Biosciences founded?
Signatur Biosciences was founded in 2022.
What industry is Signatur Biosciences in?
Signatur Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Signatur Biosciences based?
Signatur Biosciences is headquartered in London, United Kingdom.